170 related articles for article (PubMed ID: 37405505)
1. Pretreatment dual-energy CT for predicting early response to induction chemotherapy and survival in nasopharyngeal carcinoma.
Zhan Y; Wang Y; Wang P; Wang Y; Ni X; Wang J; Tang Z
Eur Radiol; 2023 Dec; 33(12):9052-9062. PubMed ID: 37405505
[TBL] [Abstract][Full Text] [Related]
2. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric dual-energy CT for distinguishing nasopharyngeal carcinoma from nasopharyngeal lymphoma.
Shen H; Yuan X; Liu D; Huang Y; Wang Y; Jiang S; Zhang J
Eur J Radiol; 2021 Mar; 136():109532. PubMed ID: 33450663
[TBL] [Abstract][Full Text] [Related]
4. Dual-energy CT in the differentiation of stage T1 nasopharyngeal carcinoma and lymphoid hyperplasia.
Wang P; Xiao Z; Tang Z; Wang J
Eur J Radiol; 2020 Mar; 124():108824. PubMed ID: 31954331
[TBL] [Abstract][Full Text] [Related]
5. Quantitative parameters derived from dual-energy computed tomography for the preoperative prediction of early recurrence in patients with esophageal squamous cell carcinoma.
Liu Y; Cheng F; Wang L; Du L; Shen H; Wang X; Zeng Z; Liu D; Tao J; Wu J; Zhang J
Eur Radiol; 2023 Nov; 33(11):7419-7428. PubMed ID: 37314470
[TBL] [Abstract][Full Text] [Related]
6. A spectral CT-based nomogram for predicting the response to induction chemotherapy in nasopharyngeal carcinoma.
Liao H; Pei W; Wei Y; Liu Y; Liang X; Bao H; Wang C; Su D
Clin Radiol; 2022 Aug; 77(8):600-606. PubMed ID: 35662510
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of malignant from benign orbital tumours using dual-energy CT.
Luo S; Sha Y; Wu J; Lin N; Pan Y; Zhang F; Huang W
Clin Radiol; 2022 Apr; 77(4):307-313. PubMed ID: 35094818
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
10. Dual-energy CT in predicting Ki-67 expression in laryngeal squamous cell carcinoma.
Wang P; Tang Z; Xiao Z; Wu L; Hong R; Duan F; Wang Y; Zhan Y
Eur J Radiol; 2021 Jul; 140():109774. PubMed ID: 34004427
[TBL] [Abstract][Full Text] [Related]
11. Quantitative parameters of enhanced dual-energy computed tomography for differentiating lung cancers from benign lesions in solid pulmonary nodules.
He C; Liu J; Li Y; Lin L; Qing H; Guo L; Hu S; Zhou P
Front Oncol; 2022; 12():1027985. PubMed ID: 36276069
[TBL] [Abstract][Full Text] [Related]
12. Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
Xie HJ; Yu YF; Sun XS; Jia GD; Luo DH; Sun R; Liu LT; Guo SS; Liu SL; Chen QY; Tang LQ; Mai HQ
Cancer Med; 2020 Dec; 9(23):8852-8863. PubMed ID: 33034945
[TBL] [Abstract][Full Text] [Related]
13. CT-based peritumoral radiomics nomogram on prediction of response and survival to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng F; Ye Z; Zhou Q
J Cancer Res Clin Oncol; 2024 Jan; 150(2):50. PubMed ID: 38286865
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of
Xian WJ; Feng YL; Wang Y; Yang M; Lu SN
Br J Radiol; 2022 Jan; 95(1129):20210279. PubMed ID: 34813375
[TBL] [Abstract][Full Text] [Related]
15. [Comparative imaging study of mediastinal lymph node from pre-surgery dual energy CT
Zhu Q; Ren C; Zhang Y; Li MJ; Wang XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):730-737. PubMed ID: 32773811
[TBL] [Abstract][Full Text] [Related]
16. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
18. Dual-energy CT for differentiating early glottic squamous cell carcinoma from chronic inflammation and leucoplakia of vocal cord: comparison with simulated conventional 120 kVp CT.
Wang P; Tang Z; Xiao Z; Wu L; Hong R; Wang J
Clin Radiol; 2021 Mar; 76(3):238.e17-238.e24. PubMed ID: 33375985
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based deep-learning prediction of induction chemotherapy treatment response in locally advanced nasopharyngeal carcinoma.
Yang Y; Wang M; Qiu K; Wang Y; Ma X
Strahlenther Onkol; 2022 Feb; 198(2):183-193. PubMed ID: 34817635
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Li PJ; Mo HY; Luo DH; Hu WH; Jin T
Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
